Energy News / Shareholders Foundation, Inc.

NASDAQ:OSIR Shareholder Alert: Lawsuit Filed in Effort to Halt the Takeover of Osiris Therapeutics, Inc.

Via: ReleaseWire

Updated 11:47 AM CDT, Wed, April 10,2019

A lawsuit was filed for investors in shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR) in connection with the proposed acquisition.

San Diego, CA -- (SBWIRE) -- 04/10/2019 -- The Shareholders Foundation announces that an investor, who currently holds shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR), filed a lawsuit against the takeover of Osiris Therapeutics, Inc.

Investors who purchased shares of Osiris Therapeutics, Inc. (NASDAQ: OSIR) and currently hold any of those NASDAQ: OSIR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: OSIR stockholders by agreeing to sell Osiris Therapeutics, Inc. cheaply via an unfair process.

On March 12, 2019, Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced that it has entered into an agreement and plan of merger with Smith & Nephew plc pursuant to which Smith & Nephew will acquire Osiris for $19.00 per share in cash, a total of approximately $660.5 million in cash.

However, plaintiff claims that the proposed consideration NASDAQ: OSIR shareholders will receive is grossly inadequate and undervalues Osiris Therapeutics. In addition, the plaintiff alleges that the process is also unfair NASDAQ: OSIR stockholders.

On March 15, 2019, NASDAQ: OSIR shares closed at $19.06 per share.

Those who are current investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqosir-shareholder-alert-lawsuit-filed-in-effort-to-halt-the-takeover-of-osiris-therapeutics-inc-1193596.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com